A
Aldeyra Therapeutics (ALDX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Aldeyra Therapeutics (ALDX)
Aldeyra Therapeutics, Inc. is a biotechnology company, which is engaged in developing immune-modulating therapies to treat ocular and systemic diseases. The Company's lead product candidate, reproxalap, is a treatment in late-stage development for dr... Read more
- USD3.97
- USD4.07
- USD3.89
- USD11.97
- 42.30%
- --
- 854.26k
- 250M
- 1.42
- -61.80%
Stock News
6 hours ago
Google is combining its Android software and Pixel hardware divisions to more broadly integrate AI
Yahoo
6 hours ago
American Express’s Profits Expected to Rise as Investors Monitor Signs of Slowdown
Yahoo
7 hours ago
Intuitive Surgical (ISRG) Q1 2024 Earnings Call Transcript
Yahoo
7 hours ago
MSCI Inc.: Here's Why I Bought This Stock With Double-Digit Dividend Growth Potential
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
